AQ BioPharma is the first company in China to specialize in the research and development of fluorine-containing new drugs
Aq BioPharma is the first company in China to specialize in the research and development of fluorine-containing new drugs and fluorine-containing pharmaceutical intermediates, and has opened up a new field of research and development of new fluorine-containing pharmaceuticals and fluorine-containing pharmaceutical intermediates in China. The company has 2,800 square meters of research and development and pilot bases and 50 acres of industrial base. After eight years of investment and development, more than 3,000 manufacturable products have been developed, of which 18 core process technologies and new drug research and development results have applied for invention patents. The company's main products include fluorine-containing pharmaceutical intermediates, piperidine, piperazine, pyrrolidine, azaindole, adamantane, aza-spiro, aza-cyclo.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 1, 2019 | Corporate Round | — | 1 | Chenghe Venture Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Chenghe Venture Capital | Yes | Corporate Round |